SF Healthcare Week: Vera Therapeutics’ announced this week that the FDA accepted the company’s filing for atacicept, a potential new treatment for IgA Nephropathy
BiotechTV - News
00:00
Momentum from Phase III and NEJM Publication
Marshall describes publishing Phase III interim results in NEJM and filing a BLA with FDA accepted for priority review.
Play episode from 00:38
Transcript
